SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Yep its posted:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DAD2 Member Profile
 
Followed By 64
Posts 5,204
Boards Moderated 0
Alias Born 03/11/09
160x600 placeholder
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/25/2017 7:31:09 AM
Compugen Announces Appointment of Dr. Michal Preminger to Board of Directors "PR Newswire (US)" - 5/25/2017 7:06:00 AM
Compugen to Present at Two Upcoming Investor Conferences in June "PR Newswire (US)" - 5/23/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/9/2017 8:01:21 AM
Compugen Reports First Quarter 2017 Results "PR Newswire (US)" - 5/9/2017 7:13:00 AM
Compugen First Quarter 2017 Conference Call Scheduled for Tuesday, May 9, 2017 at 10:00 AM ET "PR Newswire (US)" - 4/26/2017 7:00:00 AM
Compugen Announces Lead Therapeutic Candidate COM902 for CGEN-15137/TIGIT Immuno-Oncology Program "PR Newswire (US)" - 3/28/2017 7:14:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/28/2017 7:04:24 AM
Compugen to Present CGEN-15001 Autoimmune Product Candidate at Upcoming Conferences "PR Newswire (US)" - 3/22/2017 7:00:00 AM
Compugen Announces Addition of Prof. Miriam Merad to Its Scientific Advisory Board "PR Newswire (US)" - 3/8/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/15/2017 7:31:55 AM
Compugen Reports Fourth Quarter and Calendar Year 2016 Results "PR Newswire (US)" - 2/15/2017 7:20:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/14/2017 5:05:13 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/1/2017 5:07:23 PM
Compugen Fourth Quarter and Yearend 2016 Conference Call Scheduled for Wednesday, February 15, 2017 at 10:00 AM EST "PR Newswire (US)" - 1/30/2017 7:00:00 AM
Compugen's CGEN-15001 Demonstrates Restoration of Immune Tolerance in Autoimmunity "PR Newswire (US)" - 1/4/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/8/2016 6:07:36 AM
Compugen Announces Key Highlights from R&D Day "PR Newswire (US)" - 12/7/2016 11:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/7/2016 8:01:46 AM
Compugen Discloses its Cancer Immunotherapy Program Targeting TIGIT Immune Checkpoint "PR Newswire (US)" - 12/7/2016 7:22:00 AM
Compugen Appoints Senior Vice President Corporate and Business Development "PR Newswire (US)" - 12/5/2016 7:00:00 AM
Compugen to Present at 28th Annual Piper Jaffray Healthcare Conference in New York "PR Newswire (US)" - 11/21/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/14/2016 6:10:49 AM
Compugen Immune Checkpoint Program Demonstrates Potential for Development of New Cancer Immunotherapy Treatments "PR Newswire (US)" - 11/11/2016 11:45:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/7/2016 7:11:46 AM
DAD2   Tuesday, 02/07/12 07:23:17 AM
Re: Penny Roger$ post# 111
Post # of 157 
Yep its posted:

Zero revenues in the 4th quarter and the net loss for the 4th quarter was $4.4 million.

Might pull back slightly imo.


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist